Apotex Health Corp.

Apotex Delivers Strong Second Quarter 2027 Results and Raises FY2027 Guidance

– Canada Leads with 14% Revenue Growth – Adjusted EBITDA1 of $280 Million with 33% Margin – Strong Execution Supports FY 2027 Guidance Upgrade:…